Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: adhd + strattera + control  Related to the article below (Last Update: 8/4/2008)

ADHD increasingly common in older kids, CDC says
The Associated Press - Jul 23, 2008
The marketing of newer ADHD drugs like Aderall XR and Strattera to adults and older kids is pushing up use, experts said. "I think the industry does drive a ...
Gov't adds two new ADHD drugs to formulary to combat Ritalin abuse
Canada.com, Canada - Jul 18, 2008
Strattera is an alternative to Concerta, and does not contain the methylphenidate - the ingredient sought by drug abusers. Because it contains a weaker drug ...
Health bosses defend drugs for ADHD Norwich Evening News
all 9 news articles »
ADHD Group Applauds Saskatchewan's decision to list long-acting ...
CNW Telbec (Communiqu?s de presse), Canada - Jul 21, 2008
"Many of the common symptoms of ADHD, inattention, disorganization, poor impulse control, losing things and forgetfulness, make it extremely difficult for ...
New drugs might reduce Ritalin abuse
Prince Albert Daily Herald, Canada - Jul 25, 2008
Strattera, the other recently approved medication, doesn't contain methylphenidate, the stimulating chemical in most ADHD drugs. "There's less potential for ...
The ideological, illogical war against cannabis
On Line opinion, Australia - Jul 31, 2008
Some drugs our medical practitioners already legally prescribe - for instance, there is Strattera for ADHD have side-effects that include suicidal thoughts, ...

Daily Mail
Side effects include suicide and heart attacks. So why are we ...
Daily Mail, UK - Jul 7, 2008
Take the case of Strattera, the drug used to treat hyperactivity in children. There have been concerns it could cause psychosis ? hallucinations, ...
Source: Google News

Atomoxetine: The first nonstimulant for the management of attention-deficit/hyperactivity disorder. -
SL Corman, BA Fedutes, CM Culley - American Journal of Health-System Pharmacy, 2004 - pt.wkhealth.com
... attention, judgment, self-monitoring, memory, motor sequences, and impulse control,
but does ... theorized to be related to the efficacy of atomoxetine in ADHD. ...

… of OROS? methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized … -
JE Kemner, HL Starr, PE Ciccone, CG Hooper-Wood, … - Advances in Therapy, 2005 - Springer
... ie, 25% reduction from baseline ADHD-RS scores ... patients taking OROS MPH (4.8%) and
atomoxetine (5.5%) withdrew ... based studies often lack the control of randomized ...

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder -
LS Eiland, AL Guest - The Annals of Pharmacotherapy, 2004 - Harvey Whitney Books
... atomoxetine in children (ages 7?13 y) with ADHD. ... na?ve were randomized to receive
atomoxetine, methylphenidate (active control), or placebo ...

Non?stimulant medications in the treatment of ADHD -
T Banaschewski, V Roessner, RW Dittmann, P … - European Child & Adolescent Psychiatry, 2004 - Springer
... Therefore, regular control examinations of the EEG are recommended ... drugs were effec-
tive for ADHD symptoms [169 ... However, desipramine or atomoxetine may be a use ...

Children and Adolescent Exposures to Atomoxetine Hydrochloride Reported to a Poison Control Center -
SD Stojanovski, RF Robinson, SD Baker, MJ Casavant … - Clinical Toxicology, 2006 - informaworld.com
... Reported to a Poison Control Center ... INTRODUCTION Atomoxetine hydrochloride (Strattera ?
), a selective norepi ... deficit/hyperactivity disorder (ADHD) in November ...

Atomoxetine, a Novel Treatment for Attention-Deficit?Hyperactivity Disorder -
AK Christman, JD Fermo, JS Markowitz - Pharmacotherapy, 2004 - PPI
... trials to evaluate the short-term effects of atomoxetine in children and adults
have shown that atomoxetine is effective in maintaining control of ADHD. ...

CYP2D6 and Clinical Response to Atomoxetine in Children and Adolescents With ADHD. -
D MICHELSON, HA READ, DD RUFF, J WITCHER, S ZHANG, … - Journal of the American Academy of Child & Adolescent …, 2007 - jaacap.com
... is disagreement about how best to control for this ... all drugs used to treat ADHD,
clinicians treating ... over extended periods with atomoxetine should periodically ...

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/ … -
CJ Kratochvil, BS Vaughan, MJ Harrington, WJ Burke - eop, 2003 - Expert Opinion
... required in many cases for full-day symptom control, even with ... significant differences
between treatment groups on the ADHD RS (atomoxetine baseline: 39.4 ...

Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity … -
CJ KRATOCHVIL, TE WILENS, LL GREENHILL, H GAO, KD … - Journal of the American Academy of Child & Adolescent …, 2006 - jaacap.com
... a meta-analysis without a placebo control group, it is ... the ability to directly assess
atomoxetine effects on ... in detecting changes in pediatric ADHD symptoms in ...

… of Aggression or Hostility Events in Randomized, Controlled Clinical Trials of Atomoxetine for ADHD -
J Polzer, ME Bangs, S Zhang, MA Dellva, S Tauscher … - Biological Psychiatry, 2007 - Elsevier
... In this meta-analysis, we included data from placebo and active control studies
of atomoxetine in pediatric and adult patients with ADHD conducted by Lilly ...

Source: Google Scholar
 
 

Low-dose Strattera can keep ADHD under control

Last Updated: 2006-12-14 14:28:53 -0400 (Reuters Health)

NEW YORK (Reuters Health) - For kids with attention-deficit/hyperactivity disorder (ADHD) who respond well to Strattera, it may be possible to lower the dose of the drug for maintenance therapy, according to researchers.

Studies suggest that when children with ADHD are started on Strattera, also known as atomoxetine, a dose of about 1.2 milligrams per kilogram of bodyweight (mg/kg) per day is required "to attain a maximal symptom response," Dr. Jeffrey H. Newcorn and colleagues write in the medical journal Pediatrics. To see if effective maintenance treatment could be achieved using a lower dose, which would reduce drug exposure and potential tolerability problems, Newcorn, of Mount Sinai Medical Center, New York, and his team conducted a trial with 229 ADHD patients between the ages of 6 and 16 years.

The participants had responded well to an initial trial of atomoxetine. About half of them then continued treatment for up to 8 months on the same dose (1.2 to 1.8 mg/kg per day) while the others were given 0.5 mg/kg per day.

Article continues below and (thank you)
 

At the end of the study, no significant difference was observed between the groups in relapse rates. The mean change in the ADHD Rating Scale and total scores did not differ between the groups.

The participants who continued on the high-dose therapy had greater increases in heart rate compared with those on the low-dose atomoxetine, while those in the low-dose group had greater increases in weight over the course of the trial.

Lowering the dose of atomoxetine "may be an important strategy for those patients who respond very well to atomoxetine but continue to experience troublesome adverse effects that do not abate over the course of treatment," Newcorn and colleagues conclude.

SOURCE: Pediatrics, December 2006.

Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News9A ;